Concealed by the convenient: acquired von Willebrand syndrome in myeloproliferative neoplasm requires a thorough evaluation

Ann Hematol. 2022 Nov;101(11):2559-2561. doi: 10.1007/s00277-022-04943-3. Epub 2022 Aug 19.

Authors

Jessica M Stempel¹, Nikolai A Podoltsev¹, Amer M Zeidan¹, Alfred I Lee¹, Rory M Shallis²

Affiliations

¹ Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, 333 Cedar Street, PO Box 208028, New Haven, CT, 06520-8028, USA.
² Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, 333 Cedar Street, PO Box 208028, New Haven, CT, 06520-8028, USA. rory.shallis@yale.edu.

PMID: 35984499
DOI: 10.1007/s00277-022-04943-3

No abstract available

Publication types

Letter

MeSH terms

Humans
Myeloproliferative Disorders* / complications
Myeloproliferative Disorders* / diagnosis
Neoplasms*
von Willebrand Diseases* / complications
von Willebrand Diseases* / diagnosis
von Willebrand Factor

Substances

von Willebrand Factor